75968-26-2

Basic information

• Product Name: (2-{[4-(acetylamino)phenyl]sulfonyl}hydrazinylidene)acetic acid
• CAS NO: 75968-26-2
• Molecular Formula: C₁₀H₁₁N₃O₅S
• Molecular Weight: 285.2764
• Mol File: 75968-26-2.mol
• Article Data: 1

Chemical Properties

• Density: 1.49g/cm³
• Refractive Index: 1.624
• CAS DataBase Reference: (2-{[4-(acetylamino)phenyl]sulfonyl}hydrazinylidene)acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (2-{[4-(acetylamino)phenyl]sulfonyl}hydrazinylidene)acetic acid(75968-26-2)
• EPA Substance Registry System: (2-{[4-(acetylamino)phenyl]sulfonyl}hydrazinylidene)acetic acid(75968-26-2)

Safety Data

• Hazardous Substances Data: 75968-26-2(Hazardous Substances Data)

Usage

Description

(2-[4-(acetylamino)phenyl]sulfonylhydrazinylidene)acetic acid is a complex organic molecule characterized by the presence of a sulfonyl group, an acetylamino group, and a hydrazinylidene group attached to an acetic acid backbone. (2-[4-(acetylamino)phenyl]sulfonylhydrazinylidene)acetic acid has been studied for its potential use as a pharmaceutical intermediate and is currently being investigated for its anti-inflammatory and analgesic properties. Its unique structure suggests that it may have potential applications as a drug or in medical research, although further studies are required to fully understand its properties and potential uses.

Uses

Used in Pharmaceutical Industry:
(2-[4-(acetylamino)phenyl]sulfonylhydrazinylidene)acetic acid is used as a pharmaceutical intermediate for its potential role in the development of new drugs. Its complex structure and functional groups may contribute to the creation of innovative therapeutic agents.
Used in Medical Research:
In the field of medical research, (2-[4-(acetylamino)phenyl]sulfonylhydrazinylidene)acetic acid is utilized for studying its anti-inflammatory and analgesic properties. This could lead to the discovery of new treatments for pain and inflammation-related conditions.
Used in Drug Development:
(2-[4-(acetylamino)phenyl]sulfonylhydrazinylidene)acetic acid is employed in drug development to explore its potential as a new therapeutic agent. Its unique chemical structure may offer novel mechanisms of action for treating various diseases and disorders.

Upstream product

• 6000-59-5 glyoxalic acid monohydrate 

Relevant articles and documents

Glyoxylic acid hydrocarbylsulfonylhydrazones and therapeutic compositions

Glyoxylic acid hydrocarbylsulfonylhydrazones and therapeutic compositions containing the same. Said compounds are useful in treating cancer, they being active against leukemia P-388, for example.